Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.55 |
| ▸ | MAOB | P27338 | 4/20 | 0.50 |
| ▸ | ACACB | O00763 | 2/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.45 |
| ▸ | HTR2A | P28223 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28121078 | 1.00 | TAAR1 (0.55) | TAAR1MAOBACACBCYP1A2CYP2A6 | |
| SCHEMBL28121076 | 1.00 | TAAR1 (0.55) | TAAR1MAOBACACBCYP1A2CYP2A6 | |
| SCHEMBL27729576 | 0.86 | ACACB (0.50) | ACACB | |
| SCHEMBL11338351 | 0.86 | TAAR1 (0.52) | TAAR1MAOBACACBCYP1A2CYP2A6 | |
| Hydrochloric Acid SCHEMBL6573691 | 0.85 | TAAR1 (0.55) | TAAR1MAOBCYP1A2CYP2A6 | |
| SCHEMBL22563306 | 0.85 | ST14 (0.45) | MAOBACACB | |
| SCHEMBL7521694 | 0.82 | TAAR1 (0.61) | TAAR1MAOBCYP1A2CYP2A6 | |
| SCHEMBL122883 | 0.82 | ACACB (0.45) | ACACB | |
| SCHEMBL20739983 | 0.81 | ACACB (0.47) | ACACB | |
| Hydrochloric Acid SCHEMBL14157113 | 0.81 | TAAR1 (0.59) | TAAR1MAOBCYP1A2CYP2A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104277043-B | One-dimensional organic semiconductor nanotube and its preparation method and application | INSTITUTE OF CHEMISTRY, CHINESE ACADEMY OF SCIENCES (CN) | 2017-01-04 | — | — | CN | claimed |
| CN-104277043-A | One-dimensional organic semiconductor nanotube as well as preparation method and application thereof | CHINESE ACAD INST CHEMISTRY | 2015-01-14 | — | — | CN | claimed |
| EP-3483149-B1 | BENZO[D]THIAZOLE DERIVATIVE OR SALT THEREOF, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME | YUHAN CORP (KR) | 2021-01-13 | — | — | EP | disclosed |
| US-10383859-B2 | Benzo[d]thiazole derivative or salt thereof, and pharmaceutical composition including same | YUHAN CORPORATION (KR) | 2019-08-20 | — | — | US | disclosed |
| US-20190142809-A1 | Benzo[D]Thiazole Derivative Or Salt Thereof, And Pharmaceutical Composition Including Same | YUHAN CORPORATION (KR) | 2019-05-16 | — | — | US | disclosed |
| EP-3483149-A1 | BENZO[D]THIAZOLE DERIVATIVE OR SALT THEREOF, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME | Yuhan Corporation (KR) | 2019-05-15 | — | — | EP | disclosed |
| CN-104277043-B | One-dimensional organic semiconductor nanotube and its preparation method and application | INSTITUTE OF CHEMISTRY, CHINESE ACADEMY OF SCIENCES (CN) | 2017-01-04 | — | — | CN | disclosed |
| CN-104277043-A | One-dimensional organic semiconductor nanotube as well as preparation method and application thereof | CHINESE ACAD INST CHEMISTRY | 2015-01-14 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190142809-A1 | Benzo[D]Thiazole Derivative Or Salt Thereof, And Pharmaceutical Composition Including Same | ILK, SBDS, BDKRB1 | TAAR1 3745/4885MAOB 4772/4885ACACB 3776/4885 |
| US-10383859-B2 | Benzo[d]thiazole derivative or salt thereof, and pharmaceutical composition including same | ILK, SBDS, BDKRB1 | TAAR1 3745/4885MAOB 4772/4885ACACB 3776/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.